American Association for Cancer Research

2011 Frontiers in Cancer Prevention Research Conference


Frontiers in Cancer Prevention Research 2011
The world’s most comprehensive transdisciplinary cancer prevention meeting.

Frontiers in Cancer Prevention Research
October 22-25, 2011
Boston Convention and Exhibition Center
Boston, Massachusetts

Lead Supporter
Susan G. Komen for the Cure(R)

Powel H. Brown, University of Texas MD Anderson Cancer Center, Houston, TX

Waun Ki Hong, University of Texas MD Anderson Cancer Center, Houston, TX

The paradigm of cancer prevention has been evolving over the last several decades, from a promise to a possibility and now to a reality. The theme for this year’s conference is “Advancing Cancer Prevention through Technology.” Major advances have been made in our understanding of cancer genetics, cancer biology, and tumorigenesis through the application of newly developed technology. Clinical and translational researchers are now in a position to use technology to develop improved cancer risk models, identify critical growth-regulating molecules, early detection markers, and targets of future cancer preventive interventions. As the incidence of cancer continues to increase, the field of cancer prevention offers unprecedented opportunities to decrease the worldwide burden of cancer. The integrated efforts of researchers from diverse fields within cancer prevention will be required to translate basic science insights into public health benefit.

In the next few years, a dramatic increase in cancer incidence is anticipated. Now is the time for basic scientists, population-based scientists, physicians, and other health care professionals to join governments, industry, and philanthropic groups to work together to prevent cancer and reduce cancer incidence and mortality. This meeting provided a unique forum for us to share ideas, forge collaborations, and bring together investigators from every prevention subspecialty to ake progress in cancer prevention and early detection.

Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY
Tim A. Ahles, Memorial Sloan-Kettering Cancer Center, New York, NY
Christine B. Ambrosone, Roswell Park Cancer Institute, Buffalo, NY
Michael A. Andrykowski, University of Kentucky, Lexington, KY
David P. Carbone, Vanderbilt-Ingram Cancer Center, Nashville, TN
Jack Cuzick, Cancer Research UK, London, United Kingdom
Leslie G. Ford, National Cancer Institute, Bethesda, MD
Ellen R. Gritz, University of Texas MD Anderson Cancer Center, Houston, TX
John D. Groopman, Johns Hopkins University, Baltimore, MD
Ernest T. Hawk, University of Texas MD Anderson Cancer Center, Houston, TX
Seema A. Khan, Northwestern University Lurie Comprehensive Cancer Center, Chicago, IL
Karen T. Liby, Dartmouth Medical School, Hanover, NH
Sudhir Srivastava, National Cancer Institute, Rockville, MD
Young-Joon Surh, Seoul National University College of Pharmacy, Seoul, Korea (Rep.)
Sapna Syngal, Dana-Farber Cancer Institute, Boston, MA
Ian M. Thompson, Jr., University of Texas Health Science Center, San Antonio, TX

Continuing Medical Education (CME) Continuing Medical Education Activity AMA PRA Category 1 CreditsTM

* - Adobe Acrobat Reader required